Patent · US Expired

Compounds

US7674789B2 · kind B2 · utility

0Cited by
32References
71Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 24, 2006
Grant dateMar 9, 2010
Priority date
Expiry dateMar 24, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compounds of formula (I), (Ia),(Ic) and (Id), compositions, and uses thereof as an inhibitor of the p38 kinase, andwherein, inter alia

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.